Condition
Neuroblastoma in Children
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 1 (2)
P 2 (1)
Trial Status
Recruiting2
Unknown2
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07318831Phase 2Not Yet Recruiting
Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children
NCT07223606Unknown
Fecal Microbiota Transplant for Neuroblastoma in a Single Patient
NCT06872489UnknownPrimary
Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors
NCT06674265Phase 1Recruiting
Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
NCT05338541Phase 1RecruitingPrimary
Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.
Showing all 5 trials